Teva Pharmaceuticals USA settles famciclovir clear lawsuit with Novartis
Posted in Medical Patent on December 30th, 2009Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an settlement with Novartis to resolve unmistakeable suit involving Teva’s U.S. generic story of Novartis’ Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims in support of apparent breaking and damages. Teva launched its generic famciclovir tablets in the Read the rest of this entry »
